NO315957B1 - Fremgangsmåte for å bestemme protein og kreatinin i en vandig lösning i enenkelt reaksjonsbeholder - Google Patents

Fremgangsmåte for å bestemme protein og kreatinin i en vandig lösning i enenkelt reaksjonsbeholder Download PDF

Info

Publication number: NO315957B1
Authority: NO; Norway
Prior art keywords: creatinine; reaction; protein; reagent; determination
Prior art date: 1993-12-02

Application number

NO19942987A

Other languages

English (en)

Norwegian (no)

Other versions

NO942987L (no

NO942987D0 (no

Inventor

Kin-Fai Yip

Amy H Chu

Brenda Tudor

Original Assignee

Miles Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-12-02

Filing date

1994-08-12

Publication date

2003-11-17

1994-08-12 Application filed by Miles Inc filed Critical Miles Inc

1994-08-12 Publication of NO942987D0 publication Critical patent/NO942987D0/no

1995-06-06 Publication of NO942987L publication Critical patent/NO942987L/no

2003-11-17 Publication of NO315957B1 publication Critical patent/NO315957B1/no

Links

DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 title claims description 172
229940109239 creatinine Drugs 0.000 title claims description 86
238000006243 chemical reaction Methods 0.000 title claims description 68
102000004169 proteins and genes Human genes 0.000 title claims description 56
108090000623 proteins and genes Proteins 0.000 title claims description 56
238000000034 method Methods 0.000 title claims description 24
239000007864 aqueous solution Substances 0.000 title claims description 5
239000003153 chemical reaction reagent Substances 0.000 claims description 63
210000002700 urine Anatomy 0.000 claims description 29
239000012530 fluid Substances 0.000 claims description 23
238000004458 analytical method Methods 0.000 claims description 15
VYWYYJYRVSBHJQ-UHFFFAOYSA-N 3,5-dinitrobenzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1 VYWYYJYRVSBHJQ-UHFFFAOYSA-N 0.000 claims description 8
230000004520 agglutination Effects 0.000 claims description 6
238000003018 immunoassay Methods 0.000 claims description 6
238000002798 spectrophotometry method Methods 0.000 claims description 4
230000003993 interaction Effects 0.000 claims description 2
OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical group OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 claims description 2
239000003125 aqueous solvent Substances 0.000 claims 1
235000018102 proteins Nutrition 0.000 description 48
239000000523 sample Substances 0.000 description 38
238000003556 assay Methods 0.000 description 16
239000007788 liquid Substances 0.000 description 14
238000012360 testing method Methods 0.000 description 13
239000000203 mixture Substances 0.000 description 11
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 10
238000010521 absorption reaction Methods 0.000 description 9
238000005259 measurement Methods 0.000 description 9
239000000654 additive Substances 0.000 description 8
239000007853 buffer solution Substances 0.000 description 8
239000002202 Polyethylene glycol Substances 0.000 description 7
239000007983 Tris buffer Substances 0.000 description 7
238000002835 absorbance Methods 0.000 description 7
230000000996 additive effect Effects 0.000 description 7
239000000872 buffer Substances 0.000 description 7
238000001035 drying Methods 0.000 description 7
229920001223 polyethylene glycol Polymers 0.000 description 7
239000000243 solution Substances 0.000 description 7
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 6
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
238000004090 dissolution Methods 0.000 description 5
239000004816 latex Substances 0.000 description 5
229920000126 latex Polymers 0.000 description 5
238000002731 protein assay Methods 0.000 description 5
206010027525 Microalbuminuria Diseases 0.000 description 4
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 4
238000010790 dilution Methods 0.000 description 4
239000012895 dilution Substances 0.000 description 4
208000017169 kidney disease Diseases 0.000 description 4
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
108010088751 Albumins Proteins 0.000 description 3
102000009027 Albumins Human genes 0.000 description 3
108010010803 Gelatin Proteins 0.000 description 3
239000007795 chemical reaction product Substances 0.000 description 3
238000004891 communication Methods 0.000 description 3
238000001514 detection method Methods 0.000 description 3
229920000159 gelatin Polymers 0.000 description 3
239000008273 gelatin Substances 0.000 description 3
235000019322 gelatine Nutrition 0.000 description 3
235000011852 gelatine desserts Nutrition 0.000 description 3
239000001103 potassium chloride Substances 0.000 description 3
235000011164 potassium chloride Nutrition 0.000 description 3
208000035408 type 1 diabetes mellitus 1 Diseases 0.000 description 3
208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
230000002485 urinary effect Effects 0.000 description 3
HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
241000283707 Capra Species 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
239000003513 alkali Substances 0.000 description 2
HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
239000012491 analyte Substances 0.000 description 2
239000002585 base Substances 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
206010012601 diabetes mellitus Diseases 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
210000003734 kidney Anatomy 0.000 description 2
239000003550 marker Substances 0.000 description 2
239000000463 material Substances 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
201000001474 proteinuria Diseases 0.000 description 2
238000003127 radioimmunoassay Methods 0.000 description 2
239000003381 stabilizer Substances 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
229920003169 water-soluble polymer Polymers 0.000 description 2
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
108700004676 Bence Jones Proteins 0.000 description 1
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
208000024172 Cardiovascular disease Diseases 0.000 description 1
108010076119 Caseins Proteins 0.000 description 1
208000007342 Diabetic Nephropathies Diseases 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000008100 Human Serum Albumin Human genes 0.000 description 1
108091006905 Human Serum Albumin Proteins 0.000 description 1
108010058846 Ovalbumin Proteins 0.000 description 1
239000004721 Polyphenylene oxide Substances 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
239000002535 acidifier Substances 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
239000012670 alkaline solution Substances 0.000 description 1
238000012801 analytical assay Methods 0.000 description 1
238000000149 argon plasma sintering Methods 0.000 description 1
238000002820 assay format Methods 0.000 description 1
239000012496 blank sample Substances 0.000 description 1
239000006172 buffering agent Substances 0.000 description 1
239000005018 casein Substances 0.000 description 1
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
235000021240 caseins Nutrition 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000009535 clinical urine test Methods 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
230000000875 corresponding effect Effects 0.000 description 1
238000005336 cracking Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
208000033679 diabetic kidney disease Diseases 0.000 description 1
150000002016 disaccharides Chemical class 0.000 description 1
230000029142 excretion Effects 0.000 description 1
239000012634 fragment Substances 0.000 description 1
230000001434 glomerular Effects 0.000 description 1
230000005484 gravity Effects 0.000 description 1
150000002357 guanidines Chemical class 0.000 description 1
229940083094 guanine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
230000000984 immunochemical effect Effects 0.000 description 1
230000000951 immunodiffusion Effects 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000012528 membrane Substances 0.000 description 1
IZXGZAJMDLJLMF-UHFFFAOYSA-N methylaminomethanol Chemical compound CNCO IZXGZAJMDLJLMF-UHFFFAOYSA-N 0.000 description 1
150000002772 monosaccharides Chemical class 0.000 description 1
229920001542 oligosaccharide Polymers 0.000 description 1
150000002482 oligosaccharides Chemical class 0.000 description 1
229940092253 ovalbumin Drugs 0.000 description 1
239000002245 particle Substances 0.000 description 1
229940075930 picrate Drugs 0.000 description 1
OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 1
229920000570 polyether Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
229910000160 potassium phosphate Inorganic materials 0.000 description 1
235000011009 potassium phosphates Nutrition 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
239000000047 product Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
239000012070 reactive reagent Substances 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
208000024891 symptom Diseases 0.000 description 1
238000010998 test method Methods 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1

Classifications

- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/493—Physical analysis of biological material of liquid biological material urine
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6827—Total protein determination, e.g. albumin in urine
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/973—Simultaneous determination of more than one analyte
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/145555—Hetero-N
- Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Immunology (AREA)
Physics & Mathematics (AREA)
General Health & Medical Sciences (AREA)
Analytical Chemistry (AREA)
Pathology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
General Physics & Mathematics (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
Bioinformatics & Computational Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Clinical Laboratory Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Investigating Or Analysing Biological Materials (AREA)
Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

NO19942987A 1993-12-02 1994-08-12 Fremgangsmåte for å bestemme protein og kreatinin i en vandig lösning i enenkelt reaksjonsbeholder NO315957B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/160,239 US5385847A (en)	1993-12-02	1993-12-02	Method for the determination of urinary protein and creatinine

Publications (3)

Publication Number	Publication Date
NO942987D0 NO942987D0 (no)	1994-08-12
NO942987L NO942987L (no)	1995-06-06
NO315957B1 true NO315957B1 (no)	2003-11-17

Family

ID=22576091

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19942987A NO315957B1 (no)	1993-12-02	1994-08-12	Fremgangsmåte for å bestemme protein og kreatinin i en vandig lösning i enenkelt reaksjonsbeholder

Country Status (16)

Country	Link
US (1)	US5385847A (fr)
EP (1)	EP0656541B1 (fr)
JP (1)	JP3707814B2 (fr)
KR (1)	KR950019732A (fr)
AT (1)	ATE219248T1 (fr)
AU (1)	AU677106B2 (fr)
BR (1)	BR9404242A (fr)
CA (1)	CA2131146C (fr)
DE (1)	DE69430789T2 (fr)
ES (1)	ES2177560T3 (fr)
FI (1)	FI114342B (fr)
IL (1)	IL110220A (fr)
NO (1)	NO315957B1 (fr)
NZ (1)	NZ264209A (fr)
TW (1)	TW348216B (fr)
ZA (1)	ZA945837B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5464777A (en) *	1994-09-26	1995-11-07	Miles Inc.	Dry reagent for creatinine assay
US5593895A (en) *	1995-04-27	1997-01-14	Bayer Corporation	Method for the detection of protein in urine
US5804452A (en) *	1995-04-27	1998-09-08	Quidel Corporation	One step urine creatinine assays
US5610073A (en) *	1995-09-26	1997-03-11	Bayer Corporation	Use of CO2 absorbant for stabilization of dried alkaline reagent in creatinine assay
KR100461987B1 (ko) *	1995-12-06	2005-07-01	시스멕스 가부시키가이샤	데이터체크장치
US5753517A (en) *	1996-03-29	1998-05-19	University Of British Columbia	Quantitative immunochromatographic assays
US5733787A (en) *	1996-06-17	1998-03-31	Bayer Corporation	Method for the detection of creatinine
DE19811196C2 (de) *	1997-03-13	2002-05-08	Imtec Immundiagnostika Gmbh	Verwendung von Anti-Creatinin-Antikörpern oder anderen Creatinin bindenden Substanz en zur Bestimmung von Creatinin in physiologischen Flüssigkeiten und Verfahren zu ihrer Herstellung
US5822071A (en) *	1997-03-27	1998-10-13	Bayer Corporation	Spectrometer normalization system
US6436721B1 (en) *	1997-07-25	2002-08-20	Bayer Corporation	Device and method for obtaining clinically significant analyte ratios
US6566051B1 (en) *	1999-01-15	2003-05-20	Medtox Scientific, Inc.	Lateral flow test strip
US6210971B1 (en) *	1999-01-25	2001-04-03	Bayer Corporation	Assay for the detection of creatinine
US6514770B1 (en) *	1999-07-30	2003-02-04	Mitsubishi Chemical Corporation	Immunoassay
CA2397900A1 (fr) *	2000-01-21	2001-07-26	Masayuki Yokoi	Procede de quantification de creatinine dechargee dans l'urine, procede de mesure d'un composant urinaire, et appareil correspondant
US20030013129A1 (en) *	2000-12-04	2003-01-16	Tatsurou Kawamura	Method of determining solution concentration and method of examining urine
ATE398775T1 (de)	2001-05-09	2008-07-15	Axis Shield Asa	Testvorrichtung
AU2003285969A1 (en) *	2002-11-25	2004-06-18	Albert Missbichler	Method for detecting membrane-bound and/or amyloid proteins
JP4576499B2 (ja) *	2004-01-23	2010-11-10	アークレイ株式会社	蛋白質測定方法
JP5515740B2 (ja) *	2007-09-27	2014-06-11	国立大学法人新潟大学	尿中タンパク質定量用の尿前処理剤、尿前処理方法、及び尿中タンパク質定量方法。
JP6055236B2 (ja) *	2011-08-17	2016-12-27	株式会社三和化学研究所	測定方法
JP6055317B2 (ja) *	2012-01-20	2016-12-27	株式会社三和化学研究所	糖化タンパク質及びタンパク質の測定方法
US9804154B2 (en)	2013-03-12	2017-10-31	Epinex Diagnostics, Inc.	Rapid test for urine albumin and urine creatinine
CN105013546B (zh)	2015-07-03	2017-12-08	艾康生物技术(杭州)有限公司	生物样品反应盒
CN105021544B (zh)	2015-07-03	2018-02-02	艾康生物技术(杭州)有限公司	检测系统
WO2018067548A1 (fr)	2016-10-03	2018-04-12	The Children's Medicial Center Corporation	Prévention et traitement de néphropathie diabétique
MX2020006728A (es)	2018-01-09	2020-08-24	Idexx Lab Inc	Metodos para medir analito y/o proteina en muestras biologicas.
US11971415B2 (en) *	2018-07-13	2024-04-30	Siemens Healthcare Diagnostics Inc.	Microalbumin creatinine assay detection flag and methods of production and use related thereto
CN112577940A (zh) *	2019-09-30	2021-03-30	厦门大学	一种快速低成本定量检测尿液中肌酐浓度的方法
CN118177086A (zh) *	2024-03-18	2024-06-14	威海龙峰硅胶有限公司	一种可判定肾脏病变的变色硅胶猫砂的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2785057A (en) *	1953-12-08	1957-03-12	Union Central Life Insurance C	Device for testing liquids
US3705013A (en) *	1970-01-05	1972-12-05	Xerox Corp	Analytical procedures and compositions therefor
US4205954A (en) *	1978-05-26	1980-06-03	Warner-Lambert Company	Kinetic latex agglutinometry
US4426451A (en) *	1981-01-28	1984-01-17	Eastman Kodak Company	Multi-zoned reaction vessel having pressure-actuatable control means between zones
CA1183367A (fr) *	1981-09-24	1985-03-05	Ali H. Eseifan	Methode et systeme d'analyse optique
US4990075A (en) *	1988-04-11	1991-02-05	Miles Inc.	Reaction vessel for performing sequential analytical assays
IL94408A0 (en) *	1989-07-11	1991-03-10	Miles Inc	Method,reaction cassette and kit for performing analytical assays
EP0580383A3 (fr) *	1992-07-20	1995-04-12	Csir	Analyse de fluides.
US5464777A (en) *	1994-09-26	1995-11-07	Miles Inc.	Dry reagent for creatinine assay

1993
- 1993-12-02 US US08/160,239 patent/US5385847A/en not_active Expired - Lifetime
1994
- 1994-07-05 IL IL11022094A patent/IL110220A/xx not_active IP Right Cessation
- 1994-07-15 TW TW083106464A patent/TW348216B/zh active
- 1994-08-04 ZA ZA945837A patent/ZA945837B/xx unknown
- 1994-08-09 NZ NZ264209A patent/NZ264209A/en unknown
- 1994-08-12 NO NO19942987A patent/NO315957B1/no unknown
- 1994-08-30 CA CA002131146A patent/CA2131146C/fr not_active Expired - Fee Related
- 1994-08-30 KR KR1019940021492A patent/KR950019732A/ko not_active Ceased
- 1994-10-25 BR BR9404242A patent/BR9404242A/pt not_active IP Right Cessation
- 1994-11-21 AT AT94118288T patent/ATE219248T1/de not_active IP Right Cessation
- 1994-11-21 DE DE69430789T patent/DE69430789T2/de not_active Expired - Lifetime
- 1994-11-21 ES ES94118288T patent/ES2177560T3/es not_active Expired - Lifetime
- 1994-11-21 EP EP94118288A patent/EP0656541B1/fr not_active Expired - Lifetime
- 1994-11-30 AU AU79150/94A patent/AU677106B2/en not_active Ceased
- 1994-12-01 JP JP29829994A patent/JP3707814B2/ja not_active Expired - Lifetime
- 1994-12-01 FI FI945670A patent/FI114342B/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
KR950019732A (ko)	1995-07-24
BR9404242A (pt)	1995-07-25
NO942987L (no)	1995-06-06
EP0656541A3 (fr)	1996-08-28
ATE219248T1 (de)	2002-06-15
FI945670L (fi)	1995-06-03
ZA945837B (en)	1995-03-09
FI945670A0 (fi)	1994-12-01
NO942987D0 (no)	1994-08-12
JP3707814B2 (ja)	2005-10-19
EP0656541A2 (fr)	1995-06-07
FI114342B (fi)	2004-09-30
AU7915094A (en)	1995-06-08
NZ264209A (en)	1996-04-26
DE69430789D1 (de)	2002-07-18
TW348216B (en)	1998-12-21
CA2131146C (fr)	2004-03-30
AU677106B2 (en)	1997-04-10
DE69430789T2 (de)	2002-10-24
JPH07198719A (ja)	1995-08-01
CA2131146A1 (fr)	1995-06-03
IL110220A0 (en)	1994-10-21
IL110220A (en)	1999-04-11
US5385847A (en)	1995-01-31
EP0656541B1 (fr)	2002-06-12
ES2177560T3 (es)	2002-12-16

Publication	Publication Date	Title
EP0656541B1 (fr)	2002-06-12	Méthode pour la détermination de proteine et creatinine dans l'urine
US5464777A (en)	1995-11-07	Dry reagent for creatinine assay
JP3447360B2 (ja)	2003-09-16	分析検定を実施するための方法およびその反応容器
CN108152512A (zh)	2018-06-12	肝素结合蛋白检测试剂盒及其制备方法
WO2002039114A2 (fr)	2002-05-16	Dosage, reatifs et necessaires destines a detecter ou determiner la concentration des analytes
CN107860929A (zh)	2018-03-30	一种血清淀粉样蛋白a的免疫比浊检测试剂和方法
US20220113322A1 (en)	2022-04-14	Rapid measurement of total vitamin d in blood
CN105486875A (zh)	2016-04-13	视黄醇结合蛋白检测试剂盒
Owen et al.	2004	Performance characteristics of the IMMULITE 2000 erythropoietin assay
JPH09508707A (ja)	1997-09-02	改善された直線性を有する競合結合アッセイ
KR102568430B1 (ko)	2023-08-24	항 약물 항체의 신속 검출 방법
US8524452B2 (en)	2013-09-03	Measurement value lowering inhibitor for immunoassay method and immunoassay method using the same
US20140011190A1 (en)	2014-01-09	Method for performing a rapid test
Moorehead et al.	1970	An automated micromethod for determination of serum glucose, with an improved o-toluidine reagent
JPH10104233A (ja)	1998-04-24	ヒトアンチトロンビンｉｉｉの定量方法及び測定キット
Ohkubo et al.	1984	Multilayer-film analysis for urea nitrogen in blood, serum, or plasma.
CN106990057A (zh)	2017-07-28	一种检测5‑羟吲哚乙酸试剂及制备方法
CN115453120A (zh)	2022-12-09	DNase Ⅰ ELISA检测试剂盒及其使用方法
Lin et al.	2002	Development of an automated immunoassay for advanced glycosylation end products in human serum
JP2006250862A (ja)	2006-09-21	妊娠中毒症の検知方法及び検知キット
JPH0534348A (ja)	1993-02-09	リユウマチ因子検出用の新規緩衝剤及びその方法
HK40017882B (en)	2024-03-22	Analysis device and analysis method
JP2002055107A (ja)	2002-02-20	測定方法および、試薬キット
GB2269231A (en)	1994-02-02	"A colour stable chromogen composition"
MONROE	2016	6. Enzyme Channelling Immunoassay (ECIA): A Unique and Rapid Quantitative